aid: a2-biotherapeutics
name: A2 Biotherapeutics
description: >-
  A2 Biotherapeutics (A2 Bio) is a clinical-stage biotechnology company headquartered in Agoura Hills,
  California, founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang. It develops logic-gated
  cell therapies for solid tumors on its proprietary Tmod platform, a two-receptor activator/blocker
  design that lets an engineered T cell attack tumor cells which have lost an HLA allele while sparing
  normal cells that retain it. A2 Bio operates no developer API programme and publishes no product,
  clinical or research API. It is catalogued here because its corporate website runs a live WordPress
  REST API with 298 discoverable routes, and because that same install exposes two Model Context
  Protocol servers guarded by an OAuth 2.1 authorization server the host advertises through RFC 8414
  and RFC 9728 metadata.
image: https://www.a2bio.com/wp-content/uploads/A2-Bio-Email-Logo-200-x-200.jpg
url: https://raw.githubusercontent.com/api-evangelist/a2-biotherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: enriched
x-tier-reason: enrichment pass 2026-08-02
specificationVersion: '0.20'
created: '2026-08-02'
modified: '2026-08-02'
tags:
- Company
- Biotechnology
- Life Sciences
- Cell Therapy
- Immuno-Oncology
- Oncology
- Pharmaceuticals
- Clinical Trials
- Healthcare
- Model Context Protocol
- WordPress
apis:
- name: A2 Biotherapeutics WordPress REST API
  description: >-
    The live WordPress REST API served by the A2 Biotherapeutics corporate website. Route discovery is
    anonymous and advertises 298 routes across 16 namespaces; published content under wp/v2 (posts,
    pages, media, taxonomies) is readable without credentials, while writes, the WordPress Abilities
    registry and the MCP namespace are gated. This is the content-management API of the marketing
    site, not a therapeutic or research API. The OpenAPI in this repo is derived by API Evangelist
    from the provider's own live route-discovery document; A2 Bio publishes no OpenAPI itself.
  humanURL: https://www.a2bio.com/wp-json/
  baseURL: https://www.a2bio.com/wp-json/
  tags:
  - WordPress
  - Content
  - Newsroom
  - Model Context Protocol
  properties:
  - type: OpenAPI
    url: openapi/a2-biotherapeutics-wp-rest-openapi.yml
  - type: Overlay
    url: overlays/a2-biotherapeutics-wp-rest-overlay.yaml
  - type: MCPServer
    url: mcp/a2-biotherapeutics-mcp.yml
  - type: ToolCrosswalk
    url: mcp/a2-biotherapeutics-tool-crosswalk.yml
  - type: DataModel
    url: data-model/a2-biotherapeutics-data-model.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.a2bio.com/
- type: Newsroom
  url: https://www.a2bio.com/newsroom/
- type: Blog
  url: https://www.a2bio.com/newsroom/
- type: BlogRSS
  url: https://www.a2bio.com/feed/
- type: Careers
  url: https://www.a2bio.com/careers/
- type: Investors
  url: https://www.a2bio.com/about-us/investors/
- type: Contact
  url: https://www.a2bio.com/contact-us/
- type: TermsOfService
  url: https://www.a2bio.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.a2bio.com/privacy-policy/
- type: Compliance
  url: https://www.a2bio.com/california-compliance/
- type: SecondaryMarket
  url: https://forgeglobal.com/a2-biotherapeutics_stock/
- type: OpenAPI
  url: openapi/a2-biotherapeutics-wp-rest-openapi.yml
- type: Overlay
  url: overlays/a2-biotherapeutics-wp-rest-overlay.yaml
- type: MCPServer
  url: mcp/a2-biotherapeutics-mcp.yml
- type: ToolCrosswalk
  url: mcp/a2-biotherapeutics-tool-crosswalk.yml
- type: AgentSkill
  url: skills/_index.yml
- type: LLMsTxt
  url: llms/a2-biotherapeutics-llms.txt
- type: WellKnown
  url: well-known/a2-biotherapeutics-well-known.yml
- type: ContentSignal
  url: well-known/a2-biotherapeutics-robots.txt
- type: Authentication
  url: authentication/a2-biotherapeutics-authentication.yml
- type: OAuthScopes
  url: scopes/a2-biotherapeutics-scopes.yml
- type: Conventions
  url: conventions/a2-biotherapeutics-conventions.yml
- type: ErrorCatalog
  url: errors/a2-biotherapeutics-problem-types.yml
- type: DataModel
  url: data-model/a2-biotherapeutics-data-model.yml
- type: Lifecycle
  url: lifecycle/a2-biotherapeutics-lifecycle.yml
- type: Conformance
  url: conformance/a2-biotherapeutics-conformance.yml
- type: DomainSecurity
  url: security/a2-biotherapeutics-domain-security.yml
x-enrichment:
  date: '2026-08-02'
  status: enriched
  artifacts_added: 21
  pass: local-v1
x-enrichment-notes: >-
  Deliberately absent, each a verified negative on 2026-08-02: Idempotency (no idempotency contract
  exists on this surface), SDKs/Packages (nothing first-party on npm, PyPI or any registry),
  StatusPage (status.a2bio.com NXDOMAIN), Deprecation (no policy, no RFC 8594 headers), Security and
  SecurityTxt (/.well-known/security.txt 404, no disclosure page, no bug bounty), TrustCenter
  (trust.a2bio.com NXDOMAIN, no security certifications published), AgentCard
  (/.well-known/agent-card.json and /.well-known/agent.json both 404), AsyncAPI and Webhooks (no
  event surface), GitHubOrganization (github.com/A2Bio exists but carries no attribution to this
  company, so it is not claimed), Postman, Pricing, SignUp, Roadmap, Documentation, DeveloperPortal,
  APIReference, GettingStarted, Support, CLI, Sandbox and Components. The Compliance pointer is the
  company's published pharmaceutical regulatory compliance declaration, not a security attestation.